Conference

Circulating Biomarkers World Congress


The Circulating Biomarkers World Congress, organized by the SELECTBIO will take place from 20th March to 21st March 2017 at the Wyndham Boston Beacon Hill in Boston, United States Of America. The conference will cover areas like Companion Diagnostics development are converging and the various classes of Circulating Biomarkers may be developed into Companion Diagnostics enabling Biofluid/Liquid Biopsies in the future.

Visitors Attending

patrice madurai

patrice madurai

Business Head at En-NovateBoulder, United States Of America
Panagiota Kalemou

Panagiota Kalemou

IndividualThessaloniki, Greece
Marlene Barros

Marlene Barros

Associate Professor at Universidade Catu00f3lica PortuguesaViseu, Portugal
bonnie

bonnie

Boston at BioViewBoston, United States Of America
Angela Silvestro

Angela Silvestro

Scientist at NovartisCambridge, Ma
Mary Berg

Mary Berg

Physician at AmgSan Francisco, Ca

Speakers (past edition)

Speaker
Walter Koch

Walter Koch

Vice President at Roche Molecular SystemsWashington DC, United States Of America
Speaker
Lance Liotta

Lance Liotta

Professor at George Mason UniversityWashington DC, United States Of America
Speaker
Jamie Platt

Jamie Platt

Vice President, Genomic Solutions at Geneuity (Molecular Pathology Laboratory Network,...Knoxville, United States Of America
Speaker
Davina Gale

Davina Gale

Co-Founder at InivataStevenage, United Kingdom
Speaker
David Wong

David Wong

Director at UCLACalifornia City, United States Of America

Schedule & Agenda

Mon, 23 MarKeynote PresentationNanotrap Nanoparticles for Discovery and Measurement of Previously Invisible Low Abundance BiomarkersLance Liotta, Professor, George Mason University, United States of AmericaUnresolved challenges in the biomarker discovery and measurement field are 1) Very low concentration of early disease biomarkers 100 fold below the detection limit of biomarker discovery and measurement platforms, 2) Candidate body fluid biomarkers are masked by a billion fold excess quantities of resident proteins such as immunoglobulin and albumin, and 3) Degradation and perishability of candidate biomarkers ex vivo following clinical sample collection, shipping and storage. We created a new class of versatile multifunctional nanotechnology that addresses all of these challenges in one step. The technology is novel porous, buoyant, core-shell hydrogel nanoparticles containing novel high affinity reactive chemical baits that harvests biomarkers in body fluids. Upon contact with the sample, the suspended nanoparticles immediately affinity-sequester target biomarkers inside the particles, exclude albumin, fully protect the biomarkers from degradation (even at elevated temperatures), and massively concentrate the sequestered biomarkers into a small volume. The technology can dramatically (demonstrated up to 10,000 fold) improve the lower limits of detection and the precision of: a) mass spectrometry (MS) biomarker discovery, b) quantitation by multiple reaction monitoring (MRM), or c) quantification by any clinical grade immunoassay. The technology has been applied to biomarker discovery and high precision measurement of clinical analytes in all classes of body fluids including urine, saliva, sweat, and blood.
42.361416-71.066598

Map & Directions

map of Wyndham Boston Beacon Hill

5 Blossom St Boston MA 02114 USA
Boston, USA

Get Directions

Other Related Events


Medical & Pharmaceutical

More Events in Boston

All Events in Boston